Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026

Depreciation & amortization remains negative

Q3 FY2026 depreciation & amortization was $0, compared with $2.54M a year earlier. Trailing-twelve-month depreciation & amortization was $8.13M. Over 3 fiscal years it compounded at +34.1% a year.

Context

  • Depreciation & amortization amounted to 5.0% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly depreciation & amortization holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.03M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$10.47M+38.2% YoY
LTMSep 2026
$8.13M-19.5% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+38.2%——
3-year CAGR+34.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
10.47M USD
Year-over-year change
+38.2%
4-year CAGR
+26.2%

Depreciation & Amortization vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 depreciation & amortization of $8.13M is the 2nd highest of the 4 companies compared; the peer median is $832K.
  • Its year-over-year change of -19.5% is the 3rd highest of 4, against a peer median of -5.6%.
  • Depreciation & amortization amounts to 3.1% of revenue for ESTA, versus a peer median of 1.0%.
ESTA Competitors Peer median
Depreciation & Amortization for ESTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$152.29M +3.3%+7.6%9.3%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$8.13M -19.5%+34.1%3.1%
TELATELA Bio, Inc.LTM Jun 2026$832K -22.0%-5.2%1.0%
INMDInMode Ltd.LTM Mar 2026$696K -5.6%+0.7%0.2%
Peer median (excluding ESTA) $832K-5.6%+0.7%1.0%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue126.68M161.7M165.15M166.03M211.08M
Cost of Revenue41.28M55.11M58.17M56.5M64.77M
Gross Profit85.4M106.6M106.98M109.53M146.31M
Gross Margin67.4%65.9%64.8%66.0%69.3%
Research & Development18.32M20.27M26.43M19.71M20.25M
Selling, General & Admin92.23M125.98M145.58M139.81M165.07M
Operating Expenses110.54M146.25M172M159.51M185.32M
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
EBITDA(26.53M)(56.73M)(58.31M)(56.22M)(22.29M)
EBITDA Margin-20.9%-35.1%-35.3%-33.9%-10.6%
Operating Income(25.14M)(39.66M)(65.03M)(49.99M)(39.01M)
Operating Margin-19.8%-24.5%-39.4%-30.1%-18.5%
Interest Income23K87K1.02M1.48M423K
Interest Expense9.06M11.76M15.39M20.83M25.26M
Other Income / Expenses(14.57M)(33.17M)(13.56M)(34.64M)(19.01M)
Income Before Tax(39.71M)(72.82M)(78.58M)(84.63M)(58.02M)
Pre-Tax Margin-31.3%-45.0%-47.6%-51.0%-27.5%
Income Tax Expense1.43M2.39M(81K)(32K)(6.96M)
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Net Margin-32.5%-46.5%-47.5%-51.0%-24.2%
EPS (Basic)(1.72)(3.08)(3.07)(3.00)(1.72)
EPS (Diluted)(1.72)(3.08)(3.07)(3.00)(1.72)
Weighted Avg Shares23.97M24.46M25.6M28.16M29.62M
Weighted Avg Shares (Diluted)23.97M24.46M25.6M28.16M29.62M

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.